A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities

QR Code

A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities

Xuemei Liao,1,* Hui Ye,2,* Tianmei Si1 1Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, 100191, People&rsqu...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Liao X, Ye H, Si T
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	antipsychotics switch metabolic syndrome Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/2bc95ce15fe142eda43fbcfdde51a676
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
par: Fang X, et autres
Publié: (2019)

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?
par: Porfirio MC, et autres
Publié: (2017)

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia
par: Boiko AS, et autres
Publié: (2020)

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
par: Sugawara N, et autres
Publié: (2020)

Relationships between sleep patterns and metabolic profile in patients maintained on antipsychotics: a cross-sectional comparative study
par: Kiwan N, et autres
Publié: (2019)

Prevalence and Associated Factors of Metabolic Syndrome Among Patients with Severe Mental Illness at Hawassa, Southern-Ethiopia
par: Teshome T, et autres
Publié: (2020)

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
par: Sugawara N, et autres
Publié: (2016)

Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
par: Xu H, et autres
Publié: (2019)

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
par: Citrome L, et autres
Publié: (2019)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
par: Wani RA, et autres
Publié: (2015)

Esquizofrenia y su asociación con enfermedades médicas crónicas
par: Orellana,Gricel, et autres
Publié: (2017)

Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
par: Rachael K. Blackman, et autres
Publié: (2022)

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
par: Saruwatari J, et autres
Publié: (2013)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
par: Wani RA, et autres
Publié: (2015)

Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study
par: Huang YC, et autres
Publié: (2018)

Metabolic screening and its impact in children with non-syndromic intellectual disability
par: Ali YF, et autres
Publié: (2017)

Alteraciones metabólicas asociadas al uso de terapia antipsicótica
par: Rojas G,Paula, et autres
Publié: (2009)

Prevalence of metabolic syndrome and its association with depression in patients with schizophrenia
par: Suttajit S, et autres
Publié: (2013)

Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review
par: Zhang LL, et autres
Publié: (2016)

Metabolic Syndrome Predicts Poor Outcome in Acute Ischemic Stroke Patients After Endovascular Thrombectomy
par: Chen Z, et autres
Publié: (2020)

Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
par: Ward K, et autres
Publié: (2019)

Antipsychotics and risk of natural death in patients with schizophrenia
par: Chen Y, et autres
Publié: (2019)

COMPARISON OF TWO WIDELY USED ATYPICAL ANTIPSYCHOTICS OLANZAPINE VERSUS RISPERIDONE IN TERMS OF METABOLIC OUTCOMES
par: Shiraz Hussain, et autres
Publié: (2021)

Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia
par: Sicras-Mainar A, et autres
Publié: (2014)

Diabetology & metabolic syndrome

A High Incidence of Metabolic Syndrome Traits in Mexicans Points at Obesity-Related Metabolic Dysfunction
par: Bello-Chavolla OY, et autres
Publié: (2021)

Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
par: Takeshima M, et autres
Publié: (2018)

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
par: Montemagni C, et autres
Publié: (2016)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
par: Leonid Mikhaylovich Bardenshteyn, et autres
Publié: (2010)

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Publié: (2009)

Models for estimating the metabolic syndrome biological age as the new index for evaluation and management of metabolic syndrome
par: Kang YG, et autres
Publié: (2017)

Long Term Metabolic and Inflammatory Effects of Second-Generation Antipsychotics: A Study in Mentally Disordered Offenders
par: Emilia Vassilopoulou, et autres
Publié: (2021)

Metabolic syndrome: some results and prospects for solving the problem
par: X. Chu, et autres
Publié: (2016)

Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study
par: Horsdal HT, et autres
Publié: (2017)

Evaluation of Eight Anthropometric Indices for Identification of Metabolic Syndrome in Adults with Diabetes
par: Guo X, et autres
Publié: (2021)

Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk
par: Togfano RJ, et autres
Publié: (2020)

Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia
par: Chen X, et autres
Publié: (2021)

Lack of tolerable treatment options for patients with schizophrenia
par: Citrome L, et autres
Publié: (2015)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
par: Ichinose M, et autres
Publié: (2021)

Metabolic syndrome: Contradictions and Concensuses (based on the materials of IV International Congress Prediabetes and Metabolic Syndrome, Madrid, 6-9 April 2011)
par: Olga Konstantinovna Vikulova
Publié: (2011)